Protagonist Therapeutics Inc. (PTGX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Protagonist Therapeutics ...

    NASDAQ: PTGX · Real-Time Price · USD
    64.83
    -0.15 (-0.23%)
    At close: Oct 03, 2025, 3:59 PM
    64.83
    0.00%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Protagonist Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 8.64 -16.49 -4.34 -12.92
    PEG Ratio
    		 -0.02 0.37 0.88 -0.34
    PS Ratio
    		 5.47 21.69 20.13 57.91
    PB Ratio
    		 3.52 3.87 -1 -3.87
    P/FCF Ratio
    		 13.00 -18.37 -4.91 -14.54
    P/OCF Ratio
    		 12.91 -18.53 -4.95 -14.69
    OCF/S Ratio
    		 0.42 -1.17 -4.07 -3.94
    Debt / Equity Ratio
    		 0.02 0.00 -0.01 -0.01
    Quick Ratio
    		 12.48 16.71 7.62 7.55
    Current Ratio
    		 12.48 16.71 7.61 7.74
    Asset Turnover
    		 0.58 0.17 0.11 0.08
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 0.41 -0.23 0.23 0.30
    Return on Assets
    		 0.37 -0.22 -0.5 -0.35
    Return on Invested Capital
    		 0.36 -0.28 -0.57 -0.4
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.99 1.00 0.96 0.90
    Net Profit Margin
    		 0.63 -1.32 -4.64 -4.48
    Pretax Profit Margin
    		 0.64 -1.32 -4.79 -4.59
    Operating Profit Margin
    		 0.58 -1.56 -4.94 -4.6
    FCF Margin
    		 0.42 -1.18 -4.1 -3.98
    EBITDA Margin
    		 0.58 -1.51 -4.94 -4.5

    Add to Watchlist